ClinicalTrials.Veeva

Menu

Survey on Epidemiology of Hypoparathyroidism in France (Epi-Hypo)

E

European Georges Pompidou Hospital

Status

Enrolling

Conditions

Hypoparathyroidism

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02838927
EpiHypo

Details and patient eligibility

About

Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.

Full description

Very few data has been published on the epidemiology of hypoparathyroidism worldwide. None exists specifically in France. Hypoparathyroidism could led to complications: e.g. symptomatic hypocalcemia, calcifications (brain, eye and other soft tissues), nephrolithiasis/nephrocalcinosis, renal insufficiency. Here,the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.

Enrollment

3,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient fro whom chronic hypoparathyroidism is diagnosed
  • patient living in France

Exclusion criteria

  • patient who does not want his data to be collected in this registry
  • pseudo-hypoparathyroidism
  • acute hypoparathyroidism

Trial design

3,000 participants in 1 patient group

Hypoparathyroidism
Description:
No intervention.
Treatment:
Other: No intervention

Trial contacts and locations

57

Loading...

Central trial contact

Jean-Philippe Bertocchio, MD, PhD; Pascal Houillier, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems